Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Almeda Valdes, Paloma ^a   Cuevas Ramos, Daniel ^a   Mehta, Roopa ^a   Gomez Perez, Francisco J ^a   Cruz Bautista, Ivette ^a   Arellano Campos, Olimpia ^a   Navarrete Lopez, Mariana ^a   Aguilar Salinas, Carlos A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; ADIPONECTIN, HUMAN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOALPHALIPOPROTEINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MEXICO; OBESITY; PREDICTIVE VALIDITY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; MOLECULAR WEIGHT; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOALPHALIPOPROTEINEMIAS; INSULIN RESISTANCE; MALE; MEXICO; MIDDLE AGED; MOLECULAR WEIGHT; OBESITY; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77953714046     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-26     Document Type: Article

References (25)

1. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996, 120:803-812.
2. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin. More than just another fat cell hormone?. Diabetes Care 1996, 26:2442-2450.
3. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946. 10.1038/90984, 11479627.
4. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007, 56:1198-1209. 10.2337/db06-0506, 17303804.
5. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362. 10.2337/dc05-1801, 16732021.
6. Nakano Y, Tajima S, Yoshimi A, Akiyama H, Tsushima M, Tanioka T, Negoro T, Tomita M, Tobe T. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 2006, 47:1572-1582. 10.1194/jlr.D600010-JLR200, 16603722.
7. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, Inukai T, Nakano Y. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006, 55:1954-1960. 10.2337/db05-1525, 16804063.
8. Salmenniemi U, Zacharova J, Ruotsalainen E, Vauhkonen I, Pihlajamäki J, Kainulainen S, Punnonen K, Laakso M. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 2006, 90:4216-4223.
9. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51:2734-2741. 10.2337/diabetes.51.9.2734, 12196466.
10. Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab 2007, 92:2665-2671. 10.1210/jc.2006-2614, 17426091.
11. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83. 10.1006/bbrc.1999.0255, 10092513.
12. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:1473-1476.
13. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hiperinsulinemia. J Clin Endocrinol Metab 2001, 85:1930-1935.
14. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005, 54:333-339. 10.2337/diabetes.54.2.333, 15677489.
15. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, . National Heart, Lung, and Blood Institute; American Heart Association Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958, National Heart, Lung, and Blood Institute; American Heart Association.
16. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480. 10.1111/j.1464-5491.2006.01858.x, 16681555.
17. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
18. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998, 16:895-906. 10.1097/00004872-199816070-00001, 9794728.
19. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-26. 10.1152/ajpendo.00645.2007, 17957034.
20. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-8. 10.1016/S0140-6736(02)09335-2, 12114044.
21. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006, 91:3873-7. 10.1210/jc.2006-1158, 16882743.
22. Cruz M, García-Macedo R, García-Valerio Y, Gutiérrez M, Medina-Navarro R, Duran G, Wacher N, Kumate J. Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care 2004, 27:1451-3. 10.2337/diacare.27.6.1451, 15161804.
23. Yang WS, Chuang LM. Human genetics of adiponectin in the metabolic syndrome. J Mol Med 2006, 84:112-21. 10.1007/s00109-005-0011-7, 16389553.
24. Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hiperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 2007, 56:2174-2177. 10.2337/db07-0185, 17513700.
25. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004, 279:12152-12162. 10.1074/jbc.M311113200, 14699128.